FACTORS RELATED TO CARDIAC INVOLVEMENT IN MULTISYSTEM INFLAMMATORY SYNDROME (MIS-C) IN CHILDREN

Quốc Tưởng Hoàng , Minh Hiếu Lê, Thị Thùy Trang Vũ , Đại Bằng Phan , Thị Ngọc Phượng Nguyễn

Main Article Content

Abstract

Objectives: To describe the characteristic cardiac lesions and factors related to cardiac lesions in MIS-C at different time points (hospitalization, discharge, and 12 weeks after discharge). Methods: Descriptive case series study with analysis on 105 cases diagnosed with MIS -C who were admitted for treatment at the Cardiology – Rheumatology department of Children’s Hospital 2 from November 2021 to the end of March 2022. Results: Cardiac lesions were found in 2/3 of the MIS -C patients. These included coronary artery dilation (42,8%), left ventricular dysfuntion (24,8%), and pericardial effusion (9,5%). Conduction system disorders with prolonged PR interval were only found in 3 cases. Thrombocytopenia at diagnosis was noted to be associated with cardiac lesions. 50% of cardiac lesion cases recovered after 12 weeks of follow up (pericardial effusion and left ventricular dysfunction recovered completely, some cases of coronary artery lesions persisted). Conclusion: Thrombocytopenia at diagnosis was noted to be associated with cardiac lesions. Most cardiac injury in MIS -C patients recovered after 12 weeks of follow up.

Article Details

References

1. Hướng dẫn chẩn đoán và điều trị COVID-19 ở trẻ em (Bộ Y Tế) (2021).
2. N.T.N.Phung, T.T.Tran, T.H.Nguyen, T.M.T.Nguyen. Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam. Pediatrics and Neonatology. 2022;63:569-574.
3. Awasthi P, Kumar V, Naganur S, et al. Multisystem Inflammatory Syndrome in Children: Follow-Up of a Cohort from North India. The American journal of tropical medicine and hygiene. Feb 16 2022;106(4):1108-12.
4. Capone CA, Misra N, Ganigara M, et al. Six Month Follow-up of Patients With Multi-System Inflammatory Syndrome in Children. Pediatrics. 2021;148(4):e2021050973.
5. Chakraborty A, Johnson JN, Spagnoli J, et al. Long-Term Cardiovascular Outcomes of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Using an Institution Based Algorithm. Pediatric Cardiology. 2023/02/01 2023;44(2):367-380.
6. Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and outcomes of US children and adolescents with multisystem infammatory syndrome in children (MIS-C) compared with severe acute COVID-19. Jama. 2021;325(11): 1074–1087.
7. Loke YH, Berul CI, Harahsheh AS. Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease? Trends in cardiovascular medicine. Oct 2020;30(7):389-396.
8. Valverde I, Singh Y, Sanchez-de-Toledo J, et al. Acute cardiovascular manifestations in 286 children with multisystem infammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021;143(1):21–32.
9. Whittaker E, Bamford A, Kenny J, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. Jama. Jul 21 2020;324(3): 259-269. doi:10.1001/ jama.2020.10369